CRYO-CELL INTERNATIONAL, INC.: long-term debt

What this measure means

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Exact concept: us-gaap:LongTermDebt. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2016-11-30 to 2025-11-30. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• CRYO-CELL INTERNATIONAL, INC.: total assets
• CRYO-CELL INTERNATIONAL, INC.: total liabilities
• CRYO-CELL INTERNATIONAL, INC.: stockholders equity
• CRYO-CELL INTERNATIONAL, INC.: cash and cash equivalents
• CRYO-CELL INTERNATIONAL, INC.: net income or loss
• CRYO-CELL INTERNATIONAL, INC.: operating cash flow
• CRYO-CELL INTERNATIONAL, INC.: capital expenditure payments
• CRYO-CELL INTERNATIONAL, INC.: revenue
• CRYO-CELL INTERNATIONAL, INC.: financing cash flow
• CRYO-CELL INTERNATIONAL, INC.: investing cash flow
• CRYO-CELL INTERNATIONAL, INC.: retained earnings or deficit
• CRYO-CELL INTERNATIONAL, INC.: basic weighted-average shares
• CRYO-CELL INTERNATIONAL, INC.: diluted weighted-average shares
• CRYO-CELL INTERNATIONAL, INC.: basic earnings per share
• CRYO-CELL INTERNATIONAL, INC.: diluted earnings per share
• CRYO-CELL INTERNATIONAL, INC.: income tax expense or benefit
• CRYO-CELL INTERNATIONAL, INC.: net property, plant and equipment
• CRYO-CELL INTERNATIONAL, INC.: share-based compensation expense
• CRYO-CELL INTERNATIONAL, INC.: operating income or loss
• CRYO-CELL INTERNATIONAL, INC.: current assets
• CRYO-CELL INTERNATIONAL, INC.: interest expense
• CRYO-CELL INTERNATIONAL, INC.: current liabilities
• CRYO-CELL INTERNATIONAL, INC.: current accounts payable
• CRYO-CELL INTERNATIONAL, INC.: goodwill carrying amount
• CRYO-CELL INTERNATIONAL, INC.: net finite-lived intangible assets
• CRYO-CELL INTERNATIONAL, INC.: net current accounts receivable
• CRYO-CELL INTERNATIONAL, INC.: common-stock repurchase payments
• CRYO-CELL INTERNATIONAL, INC.: net inventory
• CRYO-CELL INTERNATIONAL, INC.: selling, general and administrative expense
• CRYO-CELL INTERNATIONAL, INC.: research and development expense
• CRYO-CELL INTERNATIONAL, INC.: common shares outstanding
• CRYO-CELL INTERNATIONAL, INC.: additional paid-in capital
• CRYO-CELL INTERNATIONAL, INC.: accumulated other comprehensive income or loss
• CRYO-CELL INTERNATIONAL, INC.: operating lease right-of-use asset
• CRYO-CELL INTERNATIONAL, INC.: operating lease liability
• CRYO-CELL INTERNATIONAL, INC.: gross property, plant and equipment
• CRYO-CELL INTERNATIONAL, INC.: accumulated depreciation on property, plant and equipment
• CRYO-CELL INTERNATIONAL, INC.: net intangible assets excluding goodwill
• CRYO-CELL INTERNATIONAL, INC.: other noncurrent assets
• CRYO-CELL INTERNATIONAL, INC.: other noncurrent liabilities
• CRYO-CELL INTERNATIONAL, INC.: accrued current liabilities
• CRYO-CELL INTERNATIONAL, INC.: prepaid expenses and other current assets
• CRYO-CELL INTERNATIONAL, INC.: current contract liabilities
• CRYO-CELL INTERNATIONAL, INC.: pre-tax income or loss from continuing operations
• CRYO-CELL INTERNATIONAL, INC.: profit or loss including noncontrolling interests
• CRYO-CELL INTERNATIONAL, INC.: comprehensive income or loss
• CRYO-CELL INTERNATIONAL, INC.: depreciation expense
• CRYO-CELL INTERNATIONAL, INC.: depreciation, depletion and amortization
• CRYO-CELL INTERNATIONAL, INC.: amortization of intangible assets
• CRYO-CELL INTERNATIONAL, INC.: nonoperating interest expense
• CRYO-CELL INTERNATIONAL, INC.: other nonoperating income or expense
• CRYO-CELL INTERNATIONAL, INC.: nonoperating income or expense
• CRYO-CELL INTERNATIONAL, INC.: current income tax expense or benefit
• CRYO-CELL INTERNATIONAL, INC.: deferred income tax expense or benefit
• CRYO-CELL INTERNATIONAL, INC.: interest paid, net
• CRYO-CELL INTERNATIONAL, INC.: income taxes paid, net
• CRYO-CELL INTERNATIONAL, INC.: operating lease payments
• CRYO-CELL INTERNATIONAL, INC.: change in accounts receivable
• CRYO-CELL INTERNATIONAL, INC.: change in inventories
• CRYO-CELL INTERNATIONAL, INC.: change in accounts payable

Inspect the source

Entity

CRYO-CELL INTERNATIONAL, INC. / CIK 0000862692

Captured

2026-09-20T04:59:44.726Z

SEC response SHA-256

db6274ac13e8b9460d5d6692afefc40788c565b8fd343e40b722f12a7b8f95ac

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000862692.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))